
Experienced Central Monitoring Lead and Senior CRA with over 10 years of comprehensive clinical trials experience (Phases I–IV), including a proven track record of 2+ years directly leading RBM & RBQM operations at a global level. Deep expertise in data-driven quality management, evaluating Key Risk Indicators (KRIs), and conducting Quality Tolerance Limit (QTL) assessments. Skilled in bridging central risk surveillance with practical site operations to drive inspection readiness and proactive issue mitigation. Currently enhancing expertise through post-graduate studies in Clinical Trial Operations.